Miv Therapeutics (India) Private Limited - Company Profile

It is a healthcare private limited company based in Surat, Gujarat, India, established in 2006.
2006 Surat, Gujarat, India Amalgamated
Last Updated:
Access Report
About Miv Therapeutics (India) Private Limited

Miv Therapeutics (India) Private Limited, a amalgamated private limited company, was established on 01 August 2006 in Surat, Gujarat, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33112GJ2006PTC048811. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.22 Cr.

Formerly known as Biosync Scientific Private Limited. It upholds a compliant status. Its leadership includes Murlidhar Baliram Bendale (Director), Mathew Thundiyl Thomas (Director), Brian Savio Lancelot (Director). Past directors included Abhishek Sharma, Murlidhar Baliram Bendale, Mathew Thundiyl Thomas. It holds no open charges and ₹15.86 Cr settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No. 136-B, Surat Special Economic Zone, Road No. 4, G.I.D.C, Sachin,, Surat, Gujarat, 394230.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33112GJ2006PTC048811

  • Registration Number

    048811

  • Incorporation Date

    01 August 2006

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹8.22 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 8.22 Cr
  • Company Age 19 Year, 7 Months
  • Last Filing with ROC 31 Mar 2019
  • Satisfied Charges ₹ 15.86 Cr
  • Revenue Growth **** 10.03%
  • Profit Growth **** -42.95%
  • Ebitda **** 8.50%
  • Net Worth 3.22%
  • Total Assets **** 24.27%
Company report

Miv Therapeutics (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Miv Therapeutics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Miv Therapeutics (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Murlidhar Baliram Bendale Director 22 May 2012 Current
Mathew Thundiyl Thomas Director 24 Aug 2011 Current
Brian Savio Lancelot Director 24 Aug 2011 Current
Rajesh Hiralal Shrivas Director 24 Aug 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 16 Jun 2011 Past
Pramod Abcsdd Nominee Director 10 Feb 2014 Past
Pramod Abcsdd Nominee Director 10 Feb 2014 Past
Pramod Abcsdd Nominee Director 10 Feb 2014 Past
Pramod Abcsdd Nominee Director 10 Feb 2014 Past
Pramod Abcsdd Whole-Time Director 15 Jun 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Miv Therapeutics (India).

Miv Therapeutics (India) Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 10.03% increase. The company also saw a substantial fall in profitability, with a 42.95% decrease in profit. The company's net worth moved up by a moderate rise of 3.22%.

Miv Therapeutics (India) revenue growth over time
Miv Therapeutics (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.03%
*******
*******
*******
*******
Revenue from Operations
*******
 9.97%
*******
*******
*******
*******
Total Assets
*******
 24.27%
*******
*******
*******
*******
Profit or Loss
*******
 -42.95%
*******
*******
*******
*******
Net Worth
*******
 3.22%
*******
*******
*******
*******
EBITDA
*******
 8.50%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Miv Therapeutics (India)?

In 2019, Miv Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹158,562,000.00

Charges Breakdown by Lending Institutions
  • Central Bank Of Indoa : 6.56 Cr
  • Central Bank Of India : 5.06 Cr
  • The Shamrao Vithal Co-Operative Bank Limited : 2.90 Cr
  • Dena Bank : 1.34 Cr
Latest Charge Details
Date Lender Amount Status
02 Jan 2013 The Shamrao Vithal Co-Operative Bank Limited ₹2.00 Cr Satisfied
02 Jan 2013 The Shamrao Vithal Co-Operative Bank Limited ₹9.00 M Satisfied
01 Dec 2006 Central Bank Of India ₹5.06 Cr Satisfied
04 Nov 2006 Central Bank Of Indoa ₹9.25 M Satisfied
04 Nov 2006 Central Bank Of Indoa ₹1.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Miv Therapeutics (India)?

Unlock and access historical data on people associated with Miv Therapeutics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Miv Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miv Therapeutics (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Miv Therapeutics (India)
Recent Activity within the Organization
  • Annual General Meeting

    The activity Miv Therapeutics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Miv Therapeutics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Madhavi Kishor Jawale was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jul 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Director Appointment

    The activity Madhavi Yogesh Mahajan was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jul 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Charges

    The activity A charge registered on 02 Jan 2013 via Charge ID 10399986 with The Shamrao Vithal Co-Operative Bank Limited was fully satisfied on 05 Sep 2013. was completed.

  • Charges

    The activity A charge registered on 02 Jan 2013 via Charge ID 10400735 with The Shamrao Vithal Co-Operative Bank Limited was fully satisfied on 05 Sep 2013. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Miv Therapeutics (India) Private Limited?

The CIN of Miv Therapeutics (India) Private Limited is U33112GJ2006PTC048811.

Where is Miv Therapeutics (India) Private Limited headquartered?

Miv Therapeutics (India) Private Limited is headquartered at Plot No. 136-B, Surat Special Economic Zone, Road No. 4, G.I.D.C, Sachin,, Surat, Gujarat, 394230.

When was Miv Therapeutics (India) Private Limited incorporated?

Miv Therapeutics (India) Private Limited was incorporated on 01 August 2006.

Who are the current directors of Miv Therapeutics (India) Private Limited?

The current directors of Miv Therapeutics (India) Private Limited are

What is the primary industry of Miv Therapeutics (India) Private Limited?

The primary industry of Miv Therapeutics (India) Private Limited is Manufacturing.

Is Miv Therapeutics (India) Private Limited a listed company?

Miv Therapeutics (India) Private Limited is unlisted.

What is the capital structure of Miv Therapeutics (India) Private Limited?

The authorized capital of Miv Therapeutics (India) Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.22 Cr.

What is the compliance status of Miv Therapeutics (India) Private Limited?

The compliance status of Miv Therapeutics (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available